Promise of biotech: Innovating to save lives 2021

Content from UpNext.com.au. Please don't scrape website.

Biotechnology is a huge part of our lives, from the clothes we wear and the food we eat to how we combat hunger and disease.

It has played a leading role in developing Covid-19 vaccines and treatment. This has brought about biotech innovation which is accelerating faster than ever before.

Nabiha Saklayen, CEO and Co-founder of Cellino and a panel of biotech founders will discuss the promise of biotech and the opportunities and challenges for realising its potential.

Keynote

Nabiha Saklayen, CEO and Co-founder, Cellino

Panelists

• Nabiha Saklayen, CEO and Co-founder, Cellino

• Phil Hayes-St Clair, Co-founder and CEO, Drop Bio

• John Kelly, Co-founder and CEO, Atomo Diagnostics

Moderator

Holly Ransom, CEO, Emergent

Visiting Entrepreneur Program

This event is part of the Visiting Entrepreneur Program, produced by the City of Sydney in collaboration with the startup sector and technology industry. The program is an annual City of Sydney initiative that connects international entrepreneurs with our local startup ecosystem. The 1-10 June 2021 program puts a spotlight on transformative technologies tackling major global challenges, with an emphasis on biotechnology and quantum technology. See the full program at city.sydney/vep #VEPSyd.

Accessibility

This event will include live captions. The City of Sydney aims to deliver inclusive and accessible events. If you have any access needs, please call 02 9265 9333 or email citybusiness@cityofsydney.nsw.gov.au and let us know in advance.

Event partner

Inspiring Rare Birds

Inspiring Rare Birds' mission is to create, support and promote diverse and inclusive workplaces, where opportunities in entrepreneurship and leadership exist for everyone.